ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,947Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 305

$1.28M Total Retail Price of All Prescriptions

Rank: 21 out of 305

671 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 671 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 47%.

Prescription Price

$143 was the average price of a prescription from this provider, compared to $170 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 1,233 1,128 296 1 1
METFORMIN HCL 380 333 102 2 3
ATORVASTATIN CALCIUM 315 296 81 3 7
SYNTHROID 315 303 72 3 2
SIMVASTATIN 219 193 61 5 11
PRAVASTATIN SODIUM 194 154 51 6 16
BD ULTRA-FINE PEN NEEDLE 193 167 51 7 4
GLIMEPIRIDE 188 168 42 8 6
NOVOLOG 178 143 47 9 19
ZETIA 159 128 40 10 36
LANTUS 156 131 31 11 8
CRESTOR 147 123 39 12 17
HUMULIN N 138 119 34 13 34
LISINOPRIL 137 132* 34 14 13
GABAPENTIN 127 116 46 15 24
LOSARTAN POTASSIUM 122 106 31 16 23
AMLODIPINE BESYLATE 121 116* 26 17 18
ONGLYZA 107 102* 17 18 57
INSULIN SYRINGE* 104 91 24 19 20
FENOFIBRATE* 102 97* 23 20 42
ALENDRONATE SODIUM 98 93* 30 21 26
RAMIPRIL 95 90* 23 22 50
PENTOXIFYLLINE 92 81 24 23 142
INSULIN SYRINGE* 89 84* 31 24 20
NIASPAN 88 83* 25 25 92
HUMULIN R 88 61 18 25 55
FUROSEMIDE 88 76 26 25 30
GLYBURIDE-METFORMIN HCL 84 68 14 R 28 58
HUMALOG 81 76* 23 29 10
METFORMIN HCL ER 81 66 13 29 12
POTASSIUM CHLORIDE 77 72* 17 31 37
LOSARTAN-HYDROCHLOROTHIAZIDE 76 76 11 32 52
LANTUS SOLOSTAR 75 70* 20 33 5
HUMULIN 70-30 72 72 14 34 80
LOVASTATIN 71 66* 17 35 60
HYDROCORTISONE 70 49 20 36 54
OMEPRAZOLE 64 59* 22 37 47
HUMALOG MIX 50-50 63 63 11 38 112
NOVOLOG MIX 70-30 FLEXPEN 62 57* 14 39 27
TRADJENTA 58 58 13 40 35
NOVOLIN 70-30 55 <11 <11 41 61
LOVAZA 54 49* 14 42 39
JANUVIA 54 49* 15 42 14
GLIPIZIDE ER 53 42 18 44 41
INSULIN SYRINGE* 52 <11 <11 45 20
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.